FDA.reportPublic FDA data

Complement components C3/C3c IVD, antibody

Definition
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of complement cascade components C3 and/or C3c in a clinical specimen.
GUDID devices
21
Last updated
2025-03-05 15:16:59

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB300210C3c / FITC RPabBIO SB, INC.Concentrate, 1 ml 2020-03-16
04015630971459FITC Anti-C3 Primary AntibodyVentana Medical Systems, Inc.052679780012022-12-07
B502BSB30260Tinto C3c, RPabBIO SB, INC.Predilute, 3 ml2020-08-31
B502BSB30270Tinto C3c, RPabBIO SB, INC.Predilute, 7 ml2020-08-31
B502BSB30280Tinto C3c,RPabBIO SB, INC.Predilute, 15 ml2020-08-31
B502BSB30290C3c, RPabBIO SB, INC.Concentrate, 0.1 ml2020-08-31
B502BSB30300C3c, RPabBIO SB, INC.Concentrate, 0.5 ml2020-08-31
B502BSB3002050C3c / FITCBIO SB, INC.Concentrate, 0.5 ml2020-06-15
B502BSB3002150Tinto C3c / FITCBIO SB, INC.Predilute, 15 ml2020-06-15
B502BSB300230Tinto C3c / FITCBIO SB, INC.Predilute, 3 ml2020-06-15
B502BSB300270Tinto C3c / FITC RPabBIO SB, INC.predilute, 7 ml2020-06-15
B502BSB30310C3c, RPabBIO SB, INC.Concentrate, 1 ml2020-06-15
L502BSB30021C3c / FITC RPabBIO SB, INC.Concentrate, 1 ml 2020-03-16
L502BSB3002C3c / FITC RPabBIO SB, INC.Concentrate, 1 ml 2020-03-16
B1761050Antiserum to Human C-3 (b1c/b1a)KENT LABORATORIES INC12016-09-24
B1761052Anti Human C-3 (b1c/b1a) FITCKENT LABORATORIES INC12016-09-24
B1761054C-3 (b1c/b1a) RID Plate packageKENT LABORATORIES INC12016-09-24
B1761055C-3 (b1c/b1a) RID plate kitKENT LABORATORIES INC12016-09-24
B1761190Antiserum to Human C-3 (b1c)KENT LABORATORIES INC12016-09-24
05051700010542Human Complement C3 ‘NL’ BINDARID™ Radial Immunodiffusion KitTHE BINDING SITE GROUP LIMITEDRN023.32016-09-24
05700572002482Poly Rb A-Hu C3c Complement/FITCAGILENT TECHNOLOGIES SINGAPORE PTE LTDF02012016-09-16